Preclinical Safety Evaluation of Intranasally Delivered Human Mesenchymal Stem Cells in Juvenile Mice

Preclinical Safety Evaluation of Intranasally Delivered Human Mesenchymal Stem Cells in Juvenile Mice

Mesenchymal stem cell (MSC)-based therapy is a promising therapeutic approach in the management of several pathologies, including central nervous system diseases. Previously, we demonstrated the therapeutic potential of human adipose-derived MSCs for neurological sequelae of oncological radiotherapy...

Full description

Bibliographic Details
Main Authors: Yolanda Aguilera, Nuria Mellado-Damas, Laura Olmedo-Moreno, Víctor López, Concepción Panadero-Morón, Marina Benito, Hugo Guerrero-Cázares, Catalina Márquez-Vega, Alejandro Martín-Montalvo, Vivian Capilla-González
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
mesenchymal stem cells
cell therapy
intranasal delivery
biosafety
nervous system disorders
Online Access:https://www.mdpi.com/2072-6694/13/5/1169

Internet

https://www.mdpi.com/2072-6694/13/5/1169

Similar Items